Omega Healthcare Investors, Inc. (OHI)
NYSE: OHI · Real-Time Price · USD
44.72
+0.24 (0.54%)
At close: Jan 16, 2026, 4:00 PM EST
44.71
-0.01 (-0.02%)
After-hours: Jan 16, 2026, 7:00 PM EST
OHI Stock Forecast
Stock Price Forecast
The 10 analysts that cover OHI stock have a consensus rating of "Buy" and an average price target of $45.7, which forecasts a 2.19% increase in the stock price over the next year. The lowest target is $38 and the highest is $51.
Price Target: $45.7 (+2.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OHI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Hold | 6 | 6 | 6 | 6 | 6 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy → Hold Downgrades $45 | Buy → Hold | Downgrades | $45 | +0.63% | Jan 9, 2026 |
| UBS | UBS | Strong Buy Maintains $50 → $51 | Strong Buy | Maintains | $50 → $51 | +14.04% | Jan 8, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $44 → $46 | Hold | Maintains | $44 → $46 | +2.86% | Dec 2, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +7.33% | Nov 25, 2025 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +11.81% | Nov 18, 2025 |
Financial Forecast
Revenue This Year
1.19B
from 1.05B
Increased by 12.99%
Revenue Next Year
1.28B
from 1.19B
Increased by 7.58%
EPS This Year
1.77
from 1.55
Increased by 14.14%
EPS Next Year
1.90
from 1.77
Increased by 7.32%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.4B | ||||
| Avg | 1.2B | 1.3B | ||||
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 18.7% | 18.2% | ||||
| Avg | 13.0% | 7.6% | ||||
| Low | 6.7% | -6.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.07 | 2.13 | |
| Avg | 1.77 | 1.90 | |
| Low | 1.52 | 1.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 33.7% | 20.7% | |
| Avg | 14.1% | 7.3% | |
| Low | -1.8% | -12.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.